Literature DB >> 2181001

Human immunodeficiency virus-type 1 (HIV-1) and the brain.

I Grant1, R K Heaton.   

Abstract

Infection with human immunodeficiency virus Type-1 (HIV-1), the causative agent of AIDS, can be associated with central nervous system as well as immune system disease. Advanced AIDS can be complicated by a dementia. Short of frank dementia, many AIDS patients manifest neuropsychological (NP) impairment including disturbance in speeded information processing, abstraction, learning, and recall. Data conflict on whether medically asymptomatic HIV-1 carriers have subtle NP deficits. Variations in tests chosen, criterion specification, and sample selection may all be contributing to disparate results. Longitudinal research is needed, and this should examine representative samples of HIV-1 seropositive individuals for whom approximate date of seroconversion is known and in whom sources of comorbidity (e.g., drug abuse, concurrent infections, CNS injuries) can be specified.

Entities:  

Mesh:

Year:  1990        PMID: 2181001     DOI: 10.1037//0022-006x.58.1.22

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  12 in total

1.  Increased subcortical neural activity among HIV+ individuals during a lexical retrieval task.

Authors:  April D Thames; Philip Sayegh; Kevin Terashima; Jessica M Foley; Andrew Cho; Alyssa Arentoft; Charles H Hinkin; Susan Y Bookheimer
Journal:  Neurobiol Dis       Date:  2015-10-17       Impact factor: 5.996

2.  Pathogenic and protective correlates of T cell proliferation in AIDS. HNRC Group. HIV Neurobehavioral Research Center.

Authors:  R D Schrier; C A Wiley; C Spina; J A McCutchan; I Grant
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

Review 3.  Neurotoxins and neurotoxicity mechanisms. An overview.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

4.  Neuropsychological Dysfunction among HIV Infected Drug Abusers.

Authors:  Ramani S Durvasula; Charles H Hinkin
Journal:  Am J Infect Dis       Date:  2006

5.  Evaluation of a brain-targeting zidovudine chemical delivery system in dogs.

Authors:  M E Brewster; W R Anderson; A I Webb; L M Pablo; D Meinsma; D Moreno; H Derendorf; N Bodor; E Pop
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

6.  Plasma cytokine concentrations associated with HIV/hepatitis C coinfection are related to attention, executive and psychomotor functioning.

Authors:  Ronald A Cohen; Suzanne de la Monte; Assawin Gongvatana; Hernando Ombao; Beverly Gonzalez; Kathryn N Devlin; Bradford Navia; Karen T Tashima
Journal:  J Neuroimmunol       Date:  2010-12-10       Impact factor: 3.478

Review 7.  The shifting patterns of HIV encephalitis neuropathology.

Authors:  I P Everall; L A Hansen; E Masliah
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

8.  The influence of neurocognitive impairment on HIV treatment outcomes among drug-involved people living with HIV/AIDS.

Authors:  Ifeoma Ezeabogu; Michael M Copenhaver; Jessica Potrepka
Journal:  AIDS Care       Date:  2012-01-17

9.  Characterization and sociocultural predictors of neuropsychological test performance in HIV+ Hispanic individuals.

Authors:  Monica Rivera Mindt; Desiree Byrd; Elizabeth L Ryan; Reuben Robbins; Jennifer Monzones; Alyssa Arentoft; Kaori Kubo Germano; Debra E Henniger; Susan Morgello
Journal:  Cultur Divers Ethnic Minor Psychol       Date:  2008-10

10.  Neuropsychological functioning in HIV-positive African-American women with a history of drug use.

Authors:  K I Mason; A Campbell; P Hawkins; S Madhere; K Johnson; R Takushi-Chinen
Journal:  J Natl Med Assoc       Date:  1998-11       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.